Diversified Enterprises’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$2.31M Buy
3,428
+519
+18% +$308K 0.11% 91
2026
Q2
$1.46M Buy
2,909
+49
+2% +$23.5K 0.07% 122
2026
Q1
$1.41M Buy
2,860
+57
+2% +$30.9K 0.08% 117
2025
Q4
$1.62M Buy
2,803
+1,392
+99% +$787K 0.1% 90
2025
Q3
$684K Buy
1,411
+22
+2% +$10.2K 0.05% 127
2025
Q2
$563K Sell
1,389
-99
-7% -$41.4K 0.04% 151
2025
Q1
$740K Buy
1,488
+289
+24% +$157K 0.06% 113
2024
Q4
$624K Buy
1,199
+74
+7% +$40.7K 0.06% 111
2024
Q3
$696K Buy
+1,125
New +$666K 0.08% 99

Other funds holding TMO

Diversified Enterprises's TMO Position: Q3 2026 in Review

Diversified Enterprises increased its Thermo Fisher Scientific (TMO) stake by 18% in Q3 2026, buying an estimated $308K and bringing the position to 3,428 shares worth $2.31M. The position accounts for 0.11% of the portfolio, ranked #91.

Diversified Enterprises first reported a position in TMO in Q3 2024 and has held it in 9 quarters since. 1,163 funds tracked by Wall St. Rank hold TMO as of Q3 2026.

  • Diversified Enterprises held 3,428 shares of Thermo Fisher Scientific worth $2.31M as of Q3 2026.
  • Diversified Enterprises bought 519 Thermo Fisher Scientific shares in Q3 2026, an estimated $308K.
  • Thermo Fisher Scientific made up 0.11% of Diversified Enterprises's portfolio in Q3 2026, its #91 holding.
  • Diversified Enterprises first reported a position in Thermo Fisher Scientific in Q3 2024 and has held it in 9 quarters since.
  • 1,163 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q3 2026.

Based on Diversified Enterprises's 13F filing for Q3 2026, filed 19 Oct 2026.